Phase II Study of Aflibercept in Recurrent Malignant Glioma: A North American Brain Tumor Consortium Study

keywords

  • BEVACIZUMAB
  • GLIOBLASTOMA-MULTIFORME
  • INHIBITOR
  • Life Sciences & Biomedicine
  • Oncology
  • THERAPY
  • VEGF TRAP

WoS ID

  • 000292210500022

Digital Object Identifier (DOI)

start page

  • 2689

end page

  • 2695

volume

  • 29

issue

  • 19